Genomate Health is thrilled to announce its participation in the 2025 SelectUSA Investment Summit, taking place from May 11–14 at the Gaylord National Resort and Convention Center in National Harbor, Maryland. As a leader in computational reasoning solutions for precision oncology, Genomate Health joins this prestigious event to further its mission of transforming cancer care and advancing personalized medicine.

Attendees will have the opportunity to meet Genomate Health's Founder and Chief Scientific Officer, Dr. Istvan Petak. A pioneering figure in computational oncology, Dr. Petak will share insights on how Genomate® harnesses computational reasoning to predict patient responses to targeted therapies. This cutting-edge approach empowers oncologists with actionable, data-driven insights, enhancing the precision and effectiveness of cancer treatments.

We warmly invite all attendees to connect with us at the SelectUSA Investment Summit. Schedule a meeting with our team to explore how Genomate Health is driving transformative changes in cancer care and contributing to the evolution of personalized medicine.

‍

About the SelectUSA Investment Summit

The SelectUSA Investment Summit is the highest-profile event in the United States and is dedicated to promoting foreign direct investment. Bringing together over 5,000 attendees, including more than 2,500 business investors from 90+ international markets, the Summit offers a unique opportunity for networking and partnership formation.

The 2025 Summit agenda features plenary sessions, panel discussions, pitching sessions, and exhibitions, providing an ideal platform for Genomate Health to showcase its innovative solutions and foster collaborations that support its U.S. expansion strategy.